JP2005535731A5 - - Google Patents

Download PDF

Info

Publication number
JP2005535731A5
JP2005535731A5 JP2004549842A JP2004549842A JP2005535731A5 JP 2005535731 A5 JP2005535731 A5 JP 2005535731A5 JP 2004549842 A JP2004549842 A JP 2004549842A JP 2004549842 A JP2004549842 A JP 2004549842A JP 2005535731 A5 JP2005535731 A5 JP 2005535731A5
Authority
JP
Japan
Prior art keywords
halo
alkyl
alkenyl
phenyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004549842A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005535731A (ja
JP4621502B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/020509 external-priority patent/WO2004002983A2/en
Publication of JP2005535731A publication Critical patent/JP2005535731A/ja
Publication of JP2005535731A5 publication Critical patent/JP2005535731A5/ja
Application granted granted Critical
Publication of JP4621502B2 publication Critical patent/JP4621502B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004549842A 2002-06-28 2003-06-27 疼痛の治療に有用な治療剤 Expired - Fee Related JP4621502B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39196202P 2002-06-28 2002-06-28
US41103002P 2002-09-17 2002-09-17
US41314802P 2002-09-25 2002-09-25
US41658202P 2002-10-08 2002-10-08
PCT/US2003/020509 WO2004002983A2 (en) 2002-06-28 2003-06-27 Therapeutic piperazine derivatives useful for treating pain

Publications (3)

Publication Number Publication Date
JP2005535731A JP2005535731A (ja) 2005-11-24
JP2005535731A5 true JP2005535731A5 (cg-RX-API-DMAC7.html) 2006-03-09
JP4621502B2 JP4621502B2 (ja) 2011-01-26

Family

ID=30003987

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004549842A Expired - Fee Related JP4621502B2 (ja) 2002-06-28 2003-06-27 疼痛の治療に有用な治療剤

Country Status (20)

Country Link
US (3) US7279493B2 (cg-RX-API-DMAC7.html)
EP (1) EP1556354B1 (cg-RX-API-DMAC7.html)
JP (1) JP4621502B2 (cg-RX-API-DMAC7.html)
CN (1) CN100457735C (cg-RX-API-DMAC7.html)
AT (1) ATE384698T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003247829A1 (cg-RX-API-DMAC7.html)
BR (1) BR0312322A (cg-RX-API-DMAC7.html)
CA (1) CA2491079C (cg-RX-API-DMAC7.html)
CY (1) CY1107411T1 (cg-RX-API-DMAC7.html)
DE (1) DE60318875T2 (cg-RX-API-DMAC7.html)
DK (1) DK1556354T3 (cg-RX-API-DMAC7.html)
EA (1) EA200500114A1 (cg-RX-API-DMAC7.html)
ES (1) ES2300613T3 (cg-RX-API-DMAC7.html)
IL (1) IL165862A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA04012748A (cg-RX-API-DMAC7.html)
NO (1) NO20050371L (cg-RX-API-DMAC7.html)
NZ (1) NZ537292A (cg-RX-API-DMAC7.html)
PT (1) PT1556354E (cg-RX-API-DMAC7.html)
RS (1) RS114804A (cg-RX-API-DMAC7.html)
WO (1) WO2004002983A2 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60234812D1 (de) 2001-01-29 2010-02-04 Shionogi & Co Arzneipräparat, das als wirkstoff 5-methyl-1-phenyl-2-(1h)-pyridon enthält
DE60318875T2 (de) * 2002-06-28 2009-01-15 Euro-Celtique S.A. Therapeutische piperazin-derivate für die behandlung von schmerzen
US7262194B2 (en) * 2002-07-26 2007-08-28 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US7157462B2 (en) * 2002-09-24 2007-01-02 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US7582635B2 (en) 2002-12-24 2009-09-01 Purdue Pharma, L.P. Therapeutic agents useful for treating pain
ITMI20030151A1 (it) * 2003-01-30 2004-07-31 Recordati Ind Chimica E Farma Ceutica S P A Uso di antagonisti selettivi del recettore mglu5 per il trattamento di disfunzioni neuromuscolari del tratto urinario inferiore.
ES2322707T3 (es) * 2003-07-03 2009-06-25 Euro-Celtique S.A. Derivados de 2-piridina alquino utiles para tratar el dolor.
EP1648878B9 (en) * 2003-07-24 2011-03-16 Euro-Celtique S.A. Piperidine compounds and pharmaceutical compositions containing them
PL1867644T3 (pl) * 2003-07-24 2009-10-30 Euro Celtique Sa Związki heteroarylo-tetrahydropiperydylowe przydatne w leczeniu lub zapobieganiu bólu
ES2327684T3 (es) 2003-07-24 2009-11-02 Euro-Celtique S.A. Compuestos heteroaril-tetrahidropiridilo utiles para el tratamiento o la prevencion del dolor.
MXPA06001331A (es) * 2003-08-01 2006-05-04 Euro Celtique Sa Agentes terapeuticos utiles para el tratamiento del dolor.
ES2322907T3 (es) * 2003-12-30 2009-07-01 Euro-Celtique S.A. Piperazinas utiles para el tratamiento de dolor.
KR20060087386A (ko) 2005-01-28 2006-08-02 주식회사 대웅제약 신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
EP2142529B1 (en) 2007-04-27 2013-12-25 Purdue Pharma LP Trpv1 antagonists and uses thereof
AU2011226773C1 (en) * 2007-04-27 2012-07-26 Purdue Pharma L.P. TRPV1 antagonists and uses thereof
CN101983197B (zh) 2008-04-18 2015-04-22 大熊制药株式会社 新型苯并噁嗪苯并咪唑衍生物、含有该衍生物的药物组合物及其用途
TWI510241B (zh) 2010-02-18 2015-12-01 Vtv Therapeutice Llc 苯基-雜芳基衍生物及其使用方法
US8921373B2 (en) 2010-06-22 2014-12-30 Shionogi & Co., Ltd. Compounds having TRPV1 antagonistic activity and uses thereof
KR101293384B1 (ko) 2010-10-13 2013-08-05 주식회사 대웅제약 신규 피리딜 벤조옥사진 유도체, 이를 포함하는 약학 조성물 및 이의 용도
JP6130827B2 (ja) 2011-05-17 2017-05-17 塩野義製薬株式会社 ヘテロ環化合物
RS55701B1 (sr) 2011-06-22 2017-07-31 Purdue Pharma Lp Trpv1 antagonisti koji uključuju dihidroksi supstituent i njihove upotrebe
RU2015102537A (ru) * 2012-06-28 2016-08-20 Эббви Инк. Цианогуанидины и их применение в качестве противовирусных средств
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN105944083A (zh) * 2016-05-03 2016-09-21 董桂芬 一种用于治疗纤维肌痛综合症的复方护理剂及其制备方法
WO2018023017A1 (en) 2016-07-29 2018-02-01 Janssen Pharmaceutica Nv Methods of treating prostate cancer
CN112716979B (zh) * 2021-01-26 2022-11-04 上海优祺生物医药科技有限公司 羊膜上皮细胞条件培养基的制药用途
DE102022104759A1 (de) 2022-02-28 2023-08-31 SCi Kontor GmbH Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen
WO2023239415A1 (en) * 2022-06-08 2023-12-14 Angrow Company Limited Compositions including cannabinoid and use thereof in the manufacture of a medicament for the treatment of inflammation in a subject

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI56836C (fi) * 1977-10-25 1980-04-10 Fermion Oy 4-substituerade piperazin-1-(n-aryl-n'-cyano)-karboximidamider som aer mellanprodukter vid framstaellningen av farmakologiskt vaerdefulla 6,7-dimetoxi- eller 6,7,8-trimetoxi-4-amino-2-(4-substituerade-piperazin-1-yl)-kinazoliner
US4450272A (en) * 1982-05-06 1984-05-22 American Cyanamid Company Antiatherosclerotic 1-piperazine-thicarboxamides
US4439606A (en) * 1982-05-06 1984-03-27 American Cyanamid Company Antiatherosclerotic 1-piperazinecarbonyl compounds
US5316759A (en) * 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
US5198459A (en) * 1987-07-11 1993-03-30 Sandoz Ltd. Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
US5075341A (en) * 1989-12-01 1991-12-24 The Mclean Hospital Corporation Treatment for cocaine abuse
US6204284B1 (en) * 1991-12-20 2001-03-20 American Cyanamid Company Use of 1-(substitutedphenyl)-3-azabicyclo[3.1.0]hexanes for the treatment of chemical dependencies
US5232934A (en) * 1992-07-17 1993-08-03 Warner-Lambert Co. Method for the treatment of psychomotor stimulant addiction
DE4234295A1 (de) * 1992-10-12 1994-04-14 Thomae Gmbh Dr K Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
GB9306578D0 (en) * 1993-03-30 1993-05-26 Merck Sharp & Dohme Therapeutic agents
GB9308725D0 (en) * 1993-04-27 1993-06-09 Wyeth John & Brother Ltd Piperazine derivatives
US5461047A (en) * 1993-06-16 1995-10-24 G. D. Searle & Co. 2-,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use
US5464788A (en) * 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
FR2722788B1 (fr) * 1994-07-20 1996-10-04 Pf Medicament Nouvelles piperazides derivees d'aryl piperazine, leurs procedes de preparation, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
US5556837A (en) * 1994-08-01 1996-09-17 Regeneron Pharmaceuticals Inc. Methods for treating addictive disorders
US5762925A (en) * 1994-11-03 1998-06-09 Sagen; Jacqueline Preventing opiate tolerance by cellular implantation
SK282252B6 (sk) 1995-01-11 2001-12-03 Samjin Pharmaceutical Co., Ltd. Piperazínové deriváty a farmaceutický prostriedok s ich obsahom
US5792769A (en) * 1995-09-29 1998-08-11 3-Dimensional Pharmaceuticals, Inc. Guanidino protease inhibitors
EP0850222B1 (en) * 1996-06-29 2003-05-28 Samjin Pharmaceutical Co., Ltd. Piperazine derivatives and process for the preparation thereof
JP2001502712A (ja) * 1996-10-31 2001-02-27 ノボ ノルディスク アクティーゼルスカブ 束縛されたソマトスタチン・アゴニスト及びアンタゴニスト
WO1999007672A1 (en) 1997-08-05 1999-02-18 Novo Nordisk A/S Derivatives of 2,5- and 3,5-disubstituted anilines, their preparation and use
DE69943144D1 (de) * 1998-03-31 2011-03-03 Kyowa Hakko Kirin Co Ltd Stickstoffenthaltende heterocyclische verbindungen
US6329395B1 (en) * 1998-06-08 2001-12-11 Schering Corporation Neuropeptide Y5 receptor antagonists
WO2000017163A1 (en) 1998-09-22 2000-03-30 Yamanouchi Pharmaceutical Co., Ltd. Cyanophenyl derivatives
WO2000052001A1 (en) 1999-03-03 2000-09-08 Samjin Pharmaceutical Co., Ltd. Piperazine derivatives and process for the preparation thereof
US6109269A (en) * 1999-04-30 2000-08-29 Medtronic, Inc. Method of treating addiction by brain infusion
AU2001264376A1 (en) * 2000-06-15 2001-12-24 Chaconne Nsi Co., Ltd. Urea derivative useful as an anti-cancer agent and process for preparing same
EP1313477A4 (en) 2000-07-15 2004-03-03 Smithkline Beecham Corp COMPILATIONS AND METHODS
EP1311478B1 (en) * 2000-08-21 2006-06-07 Pacific Corporation Novel (thio)urea compounds and the pharmaceutical compositions containing the same
NZ523882A (en) * 2000-08-21 2004-11-26 Pacific Corp Novel thiourea derivatives and the pharmaceutical compositions containing the same
WO2002018335A1 (en) 2000-08-28 2002-03-07 Yamanouchi Pharmaceutical Co., Ltd. Cyclic amine derivatives
MY138086A (en) 2001-09-13 2009-04-30 Smithkline Beecham Plc Novel urea derivative as vanilloid receptor-1 antagonist
RS63204A (sr) 2002-01-17 2006-10-27 Neurogen Corporation Supstituisani analozi hinazolin-4-ilamina kao modulatori kapsaicina
ATE416168T1 (de) 2002-02-15 2008-12-15 Glaxo Group Ltd Modulatoren des vanilloidrezeptors
US20030158188A1 (en) * 2002-02-20 2003-08-21 Chih-Hung Lee Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
US7074805B2 (en) * 2002-02-20 2006-07-11 Abbott Laboratories Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
US7105505B2 (en) * 2002-04-18 2006-09-12 Schering Corporation Benzimidazole derivatives useful as histamine H3 antagonists
CN100360130C (zh) * 2002-04-18 2008-01-09 先灵公司 用作组胺h3拮抗剂的1-(4-哌啶基)苯并咪唑酮
US7220862B2 (en) * 2002-06-05 2007-05-22 Bristol-Myers Squibb Company Calcitonin gene related peptide receptor antagonists
MY135686A (en) * 2002-06-24 2008-06-30 Schering Corp Indole derivatives useful as histamine h3 antagonists
DE60318875T2 (de) 2002-06-28 2009-01-15 Euro-Celtique S.A. Therapeutische piperazin-derivate für die behandlung von schmerzen
DE60318716T2 (de) * 2002-08-21 2009-01-08 Astrazeneca Ab Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
TW200418835A (en) 2003-01-24 2004-10-01 Tanabe Seiyaku Co A pyrazolopyrimidine compound and a process for preparing the same

Similar Documents

Publication Publication Date Title
TW199156B (cg-RX-API-DMAC7.html)
Diana et al. Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity
ES2316818T3 (es) Nuevos derivados de glicosido de tiofeno, procedimiento para su preparacion, medicamentos que contienen a estos compuestos y su uso.
CA2876690C (en) Dihydropyrimidine compounds and their application in pharmaceuticals
JP2007504284A5 (cg-RX-API-DMAC7.html)
CA2513081A1 (en) Pyrrolopyridazine derivatives
JP2005525291A5 (cg-RX-API-DMAC7.html)
JP2002523371A (ja) ウイルス感染および関連疾患を治療または予防するための化合物、組成物および方法
EP2310010A2 (en) Chemical compounds 251
RU2002107975A (ru) Глюкопиранозилоксипиразольные производные, лекарственные композиции, содержащие эти производные, и промежуточные соединения для их получения
CA2505368A1 (en) Trans-9,10-dehydroepothilone c and d, analogs thereof and methods of making the same
HRP20110252T1 (hr) Fenil-karboksamidni spojevi korisni za liječenje boli
JPH0283384A (ja) 新規化合物、その製法及びそれを含む医薬組成物
KR20080034436A (ko) 암 치료에 사용되는 티아졸 유도체 및 유사체
RU2012126083A (ru) Производные аминооксазина
KR100608416B1 (ko) 2-(n-시아노이미노)티아졸리딘-4-온 유도체
CN102584690A (zh) 吡啶-2-酮类化合物,其制备方法以及所述吡啶-2-酮类化合物的应用
KR900004126B1 (ko) 아릴피페라지닐-에틸(또는 부틸)-페닐-헤테로시클릭 화합물
JP2026503618A5 (cg-RX-API-DMAC7.html)
FR2965262A1 (fr) Derives de nicotinamide, leur preparation et leur application en therapeutique
KR20020002394A (ko) 비만증 예방 또는 치료용 약제를 제조하기 위한,폴리사이클릭 2-아미노-티아졸계의 용도
EP0321115A1 (en) Carboxamide derivatives having tetrazole and thiazole rings and their use
KR20010102390A (ko) 폴리사이클릭 2-아미노-티아졸 시스템, 이의 제조방법 및이를 함유하는 약제
CN112739680A (zh) Dp拮抗剂
CN115515603A (zh) 用于治疗戊型肝炎的双环和单环核苷类似物